Twist Bioscience
Twist Bioscience Corp is an American synthetic biology provider manufacturing high-throughput synthetic DNA molecules. The company utilizes a silicon-based DNA synthesis platform to produce synthetic genes, oligonucleotide pools, next-generation sequencing target enrichment panels, and antibody libraries. Revenue is primarily generated through the sale of custom synthetic DNA products, library design tools, and research service contracts. Its end markets include academic research institutions, biotechnology firms, pharmaceutical developers, agricultural companies, and industrial chemical producers globally. Twist Bioscience holds a leading position in the synthetic biology sector through its proprietary miniaturized DNA manufacturing technology. The company is headquartered in South San Francisco, California, and its shares are listed on the Nasdaq Global Select Market.
12 of the funds FundTelligence covers report a position in Twist Bioscience.
- Legal name
- TWIST BIOSCIENCE CORP
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 12
- Exposure themes
- Genomics & Profiling, Genomic Tools, Precision Medicine & Genomics
Funds holding Twist Bioscience
- Allianz Global Equity Insights — Allianz Global Investors · 3.39 % (largest positions only, September 2026)
- Pensum Kairos — Pensum · 2.55 % (full portfolio disclosed, June 2026)
- Artisan Global Discovery Fund — Artisan Partners · 2.4 % (largest positions only, September 2026)
- T. Rowe Price Global Focused Growth Equity Fund — T. Rowe Price · 1.08 % (full portfolio disclosed, September 2026)
- SEB Nordamerikafond Små och Medelstora Bolag — SEB · 0.89 % (full portfolio disclosed, June 2026)
- BlackRock iShares Healthcare Innovation UCITS ETF — BlackRock · 0.68 % (full portfolio disclosed, October 2026)
- BlackRock iShares NASDAQ US Biotechnology UCITS ETF — BlackRock · 0.52 % (full portfolio disclosed, October 2026)
- T. Rowe Price US Smaller Companies Equity Fund — T. Rowe Price · 0.3 % (full portfolio disclosed, September 2026)
Showing the 8 largest of 12 funds holding it.